{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:32:22Z","timestamp":1793655142186,"version":"4.5.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4570,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1600-6143.2010.03129.x","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T16:25:06Z","timestamp":1272558306000},"page":"1401-1413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":227,"title":["Everolimus Plus Reduced\u2010Exposure CsA versus Mycophenolic Acid Plus Standard\u2010Exposure CsA in Renal\u2010Transplant Recipients"],"prefix":"10.1016","volume":"10","author":[{"given":"H.Tedesco","family":"Silva Jr.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cibrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Panis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zibari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2010.03129.x_bib1","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.transproceed.2007.09.008","article-title":"Proliferation signal inhibitors in transplantation: Questions at the cutting edge of everolimus therapy","volume":"39","author":"Chapman","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/01.tp.0000188135.04259.2e","article-title":"Estimated one\u2010year glomerular filtration rate is the best predictor of long\u2010term graft function following renal transplant","volume":"81","author":"Salvadori","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.transproceed.2009.02.036","article-title":"The first year renal function as a predictor of long\u2010term graft survival after kidney transplantation","volume":"41","author":"Helal","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.transproceed.2009.01.066","article-title":"First year renal function as a predictor of kidney allograft outcome","volume":"41","author":"Resende","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: Pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000164352.65613.24","article-title":"Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: A 3\u2010year randomized, multicenter, phase III study","volume":"80","author":"Lorber","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1432-2277.2006.00414.x","article-title":"12\u2010month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients","volume":"20","author":"Tedesco\u2010Silva","year":"2007","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","article-title":"Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6\u2010month safety and efficacy results of two randomized studies","volume":"4","author":"Vitko","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib9","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1600-6143.2005.01063.x","article-title":"Three\u2010year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients","volume":"5","author":"Vitko","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.TP.0000141094.34903.54","article-title":"Everolimus (Certican) 12\u2010month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients","volume":"78","author":"Vitko","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/01.TP.0000140486.97461.49","article-title":"Everolimus and reduced\u2010exposure cyclosporine in de novo renal\u2010transplant recipients: A three\u2010year phase II, randomized, multicenter, open\u2010label study","volume":"78","author":"Nashan","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0b013e318166927b","article-title":"Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness","volume":"85","author":"Chan","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib13","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/01.TP.0000162434.62591.F3","article-title":"Concentration\u2010controlled everolimus (Certican): Combination with reduced dose calcineurin inhibitors","volume":"79","author":"Pascual","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007691-200410000-00007","article-title":"Everolimus therapeutic concentration range defined from a prospective trial with reduced\u2010exposure cyclosporine in de novo kidney transplantation","volume":"26","author":"Kovarik","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody\u2010mediated rejection criteria \u2013 an addition to the Banff 97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":"Predicting glomerular filtration rate after kidney transplantation","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib19","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2006.01535.x","article-title":"Impact of cyclosporine reduction with MMF: A randomized trial in chronic allograft dysfunction. The \u2018reference\u2019 study","volume":"6","author":"Frimat","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1600-6143.2006.01398.x","article-title":"Mycophenolate mofetil and sirolimus combination in renal transplantation","volume":"6","author":"Grinyo","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000061606.64917.BE","article-title":"A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation","volume":"75","author":"Pascual","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0012.2005.00326.x","article-title":"Therapeutic drug monitoring for everolimus in kidney transplantation using 12\u2010month expo\u2010sure, efficacy, and safety data","volume":"19","author":"Lorber","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post\u2010transplant renal function in the first year predicts long\u2010term kidney transplant survival","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib24","unstructured":"Novartis Pharma AG. Data on file. 2009."},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/01.TP.0000132278.00441.CF","article-title":"A comparative prospective study of two available solutions for kidney and liver preservation","volume":"77","author":"Pedotti","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/TP.0b013e318192dd56","article-title":"A systematic approach to minimizing wound problems for de novo sirolimus\u2010treated kidney transplant recipients","volume":"87","author":"Tiong","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":"Comparison of sirolimus vs mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation","volume":"3","author":"Valente","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03129.x_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00003495-200666040-00009","article-title":"Everolimus: A review of its use in renal and cardiac transplantation","volume":"66","author":"Dunn","year":"2006","journal-title":"Drugs"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2010.03129.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522144254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522144254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2010.03129.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:49:59Z","timestamp":1761626999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522144254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1600613522144254"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03129.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus Plus Reduced\u2010Exposure CsA versus Mycophenolic Acid Plus Standard\u2010Exposure CsA in Renal\u2010Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03129.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}